She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh ...

Sandoz's antitrust suit against Amgen, the FDA’s interchangeability designation for Celltrion’s adalimumab biosimilar, and ...

The prescribed dosage for dexamethasone may vary depending on a person’s individual treatment plan. Factors such as your medical history and body weight may also affect your dosage of dexamethasone.

Drug calculations for the formulation of dosage forms and associated preparations are key activities in pharmaceutical compounding. Calculations determine the amount of drug identified in the request ...

Patients who received infliximab, adalimumab, and etanercept were at increased risk for various fungal infections ... Investigators explored correlations between Food and Drug Administration-approved ...

The prescribed dosage for ciprofloxacin may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

This table may help to avoid unnecessary drug loss and expenditures due to ... 14 days Prescribing information Etanercept powder Enbrel (Immunex Corporation [Amgen and Wyeth Pharmaceuticals ...

Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step ...

Psoriatic arthritis (PsA) is a chronic, autoimmune, inflammatory form of arthritis that causes painful ... While there are a variety of treatments available, many PsA patients are undertreated, making ...

54. Gilead Sciences said Monday that a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women with a less common, but aggressive form of breast cancer.

and not restricted to those with forms of the disease tied to specific characteristics such as high levels of eosinophils. AZ's head of biopharma R&D Mene Pangalos said the new device would help ...

Apellis is expecting decisions on the drug form regulators in the UK, Switzerland, Canada, and Australia early next year. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with ...